Elevation Historical Cash Flow
ELEV Stock | USD 0.38 0.01 2.70% |
Analysis of Elevation Oncology cash flow over time is an excellent tool to project Elevation Oncology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 2.3 M or Change In Working Capital of 4 M as it is a great indicator of Elevation Oncology ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Elevation Oncology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Elevation Oncology is a good buy for the upcoming year.
Elevation | Build AI portfolio with Elevation Stock |
About Elevation Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Elevation balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Elevation's non-liquid assets can be easily converted into cash.
Elevation Oncology Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Elevation Oncology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Elevation Oncology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevation Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.At this time, Elevation Oncology's Change In Working Capital is fairly stable compared to the past year. Depreciation is likely to climb to about 25.9 K in 2025, whereas Change In Cash is likely to drop slightly above 198.6 K in 2025.
2022 | 2024 | 2025 (projected) | Stock Based Compensation | 3.2M | 4.3M | 2.3M | Net Borrowings | 29.5M | 26.6M | 23.9M |
Elevation Oncology cash flow statement Correlations
Click cells to compare fundamentals
Elevation Oncology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.